FDA Inspection
Biocon Biologics LimitedBiocon Biologics Limited – FDA Inspection, Apr 7, 2017
Record Details
This FDA Inspection record concerns Biocon Biologics Limited, with an inspection on April 7, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Lakshmi Ran Narasimhan (Issuing Officer)
- Lindsey J. Brown (Issuing Officer)
- Michael Shanks (Issuing Officer)
- Reyes Candau-Chacon (Issuing Officer)
View Company Profile
ID · 0aefbacd-66f3-4b02-a58d-c1baf8deb150
Inspection Facts
- Inspection number
- 1011627
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Biocon Biologics Limited
12| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2019 | Not classified | Office of Inspections and Investigations | |
| August 30, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2019 | Not classified | Office of Inspections and Investigations | |
| May 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biocon Biologics Limited
- FDA Inspection 1245708 - 2024-07-26
- FDA Inspection 1114628 - 2019-09-19
- FDA Inspection 1100840 - 2019-08-30
- FDA Inspection 1080031 - 2019-02-15
- FDA Inspection 1050980 - 2018-05-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.